BCL6 rearrangements (3q27) are the most common chromosomal abnormalities in diffuse large B-cell lymphoma (DLBCL), with numerous immunoglobulin (Ig) and non-Ig genes as partners. In DLBCL, the translocations occur predominantly in the "major breakpoint region" encompassing the first noncoding exon and a part of the first intron of BCL6; few cases with "alternative breakpoint cluster" located 245-285 kb 5' BCL6 were also described. The regulatory sequences of known Ig and non-Ig partners replace the 5' untranslated region of the BCL6 in the same transcriptional orientation. Contrary to Ig/BCL6 fusions typical by high BCL6 gene expression, in non-Ig/BCL6 translocations were observed unexpectedly low BCL6 mRNA levels. From the clinical point of view, the survival rate of DLBCL patients with non-Ig partners is inferior to those with Ig/BCL6 translocations, suggesting that non-Ig/BCL6 fusion is a poor prognostic indicator. Hereby we provide comprehensive information about known non-Ig translocation partners and clinical consequences of BCL6 rearrangements in DLBCL. Moreover, we describe a novel reciprocal translocation t(3;10) in refractory patient with DLBCL with the breaking points at 5' untranslated region of BCL6 and 5' untranslated region of the RASGEF1A gene on chromosome 10q11.21 loci; this rearrangement was associated with low BCL6 and RASGEF1A gene expressions. Our patient harbouring dual chromosomal rearrangement involving BCL2 and BCL6 genes relapsed three-times and died soon; thus, further supporting the notion that non-Ig/BCL6 fusion is a poor prognostic indicator of DLBCL. There is evidence of prognostic value of BCL6 rearrangements also in rituximab era.

Department of Clinical and Molecular Pathology Faculty of Medicine and Dentistry Palacky University Olomouc and the University Hospital Olomouc Hnevotinska 3 77900 Olomouc Czech Republic

Department of Hemato Oncology Faculty of Medicine and Dentistry Palacky University Olomouc and the University Hospital Olomouc Hnevotinska 3 77900 Olomouc Czech Republic

Department of Immunology Faculty of Medicine and Dentistry Palacky University Olomouc Hnevotinska 3 77900 Olomouc Czech Republic

Zobrazit více v PubMed

J Hematol Oncol. 2012 Sep 11;5:54 PubMed

J Immunol. 2004 Jul 15;173(2):1158-65 PubMed

Haematologica. 2004 Aug;89(8):965-72 PubMed

Med Oncol Tumor Pharmacother. 1988;5(1):17-32 PubMed

Nature. 2004 Dec 2;432(7017):635-9 PubMed

Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6947-52 PubMed

Nucleic Acids Res. 2012 Sep;40(16):7776-87 PubMed

Nat Immunol. 2007 Jul;8(7):705-14 PubMed

Cell Cycle. 2012 Sep 15;11(18):3358-69 PubMed

Int J Oncol. 2012 Sep;41(3):995-1004 PubMed

Cancer Res. 2002 Nov 1;62(21):6224-30 PubMed

Genes Chromosomes Cancer. 1998 Dec;23(4):328-36 PubMed

Blood. 2009 Dec 17;114(26):5315-21 PubMed

Leukemia. 2007 Mar;21(3):515-23 PubMed

Genes Chromosomes Cancer. 2005 Aug;43(4):414-23 PubMed

Leuk Lymphoma. 2014 Jul;55(7):1584-90 PubMed

Leukemia. 1996 Apr;10(4):579-87 PubMed

Cancer Genet Cytogenet. 1995 May;81(1):56-65 PubMed

Intern Med. 2011;50(8):905-8 PubMed

Haematologica. 2010 Mar;95(3):509-13 PubMed

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Sep;157(3):239-47 PubMed

Cancer Genet Cytogenet. 2008 Apr 15;182(2):144-9 PubMed

Hum Pathol. 2006 Aug;37(8):1093-9 PubMed

BMC Res Notes. 2011 Sep 06;4:324 PubMed

J Clin Oncol. 2004 Sep 1;22(17):3498-506 PubMed

Cancer Res. 1997 Jan 1;57(1):7-12 PubMed

Ann Hematol. 1997 May;74(5):247-50 PubMed

N Engl J Med. 2004 Apr 29;350(18):1828-37 PubMed

Cancer Genet Cytogenet. 2004 Sep;153(2):115-21 PubMed

Blood. 2009 May 28;113(22):5536-48 PubMed

Int J Hematol. 1995 Dec;62(4):247-52 PubMed

Clin Med Insights Case Rep. 2014 Oct 01;7:117-21 PubMed

Blood. 2000 Apr 15;95(8):2719-21 PubMed

Oncogene. 2000 Oct 5;19(42):4941-5 PubMed

Immunol Rev. 2012 May;247(1):172-83 PubMed

Oncogene. 1995 Jun 1;10 (11):2171-8 PubMed

Neoplasma. 2014;61(5):491-504 PubMed

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3879-84 PubMed

Blood. 2003 Aug 15;102(4):1443-8 PubMed

Genes Chromosomes Cancer. 2008 Dec;47(12):1038-48 PubMed

PLoS One. 2013;8(2):e57903 PubMed

Cancer Genet Cytogenet. 1984 Sep;13(1):17-28 PubMed

Blood. 2002 Apr 1;99(7):2624-5 PubMed

Cancer Res. 1983 Jun;43(6):2975-84 PubMed

Genes Chromosomes Cancer. 2005 Feb;42(2):149-57 PubMed

Haematologica. 2010 Jan;95(1):96-101 PubMed

Leukemia. 2002 Nov;16(11):2309-17 PubMed

Int J Mol Med. 2000 May;5(5):485-92 PubMed

Oncogene. 2002 Jan 17;21(3):368-76 PubMed

Blood. 2009 Sep 10;114(11):2273-9 PubMed

Aging (Albany NY). 2011 Jul;3(7):692-7 PubMed

Br J Haematol. 1999 May;105(2):437-40 PubMed

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11294-9 PubMed

Blood. 2013 May 30;121(22):4551-4 PubMed

FEBS J. 2009 Aug;276(16):4607-16 PubMed

Blood. 2010 Feb 4;115(5):975-84 PubMed

Leuk Lymphoma. 2002 Jul;43(7):1375-81 PubMed

J Clin Exp Hematop. 2006 Nov;46(2):43-53 PubMed

Br J Haematol. 1992 Jan;80(1):15-20 PubMed

Cancer Genet Cytogenet. 1997 Dec;99(2):102-7 PubMed

Leukemia. 2001 Sep;15(9):1475-84 PubMed

Eur J Haematol. 1999 Mar;62(3):184-90 PubMed

Br J Haematol. 2002 May;117(2):322-32 PubMed

Ann Hematol. 2008 Feb;87(2):151-3 PubMed

Nature. 2001 Jul 19;412(6844):341-6 PubMed

Leukemia. 2000 Jan;14(1):169-82 PubMed

Blood. 2000 Oct 15;96(8):2907-9 PubMed

Aging (Albany NY). 2011 Mar;3(3):262-76 PubMed

Histopathology. 2010 Dec;57(6):785-95 PubMed

Clin Cancer Res. 2006 Nov 15;12(22):6611-6 PubMed

BMC Mol Biol. 2008 Jul 31;9:69 PubMed

Cancer Res. 2000 May 1;60(9):2335-41 PubMed

Cancer Genet Cytogenet. 2007 Oct 1;178(1):73-6 PubMed

Cancer Genet Cytogenet. 1998 Jul 1;104(1):19-27 PubMed

Genes Chromosomes Cancer. 2001 Nov;32(3):281-4 PubMed

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1398-403 PubMed

Genes Chromosomes Cancer. 2011 Jan;50(1):43-50 PubMed

Oncogene. 1999 Dec 23;18(56):7994-9 PubMed

Genes Cells. 2000 Apr;5(4):277-87 PubMed

Pathol Biol (Paris). 2007 Feb;55(1):73-83 PubMed

Leukemia. 2008 Jun;22(6):1262-6 PubMed

EMBO J. 2003 Jun 16;22(12):3039-49 PubMed

Brain Pathol. 2003 Oct;13(4):534-8 PubMed

Cancer Genet Cytogenet. 2007 Jan 1;172(1):45-53 PubMed

Cancer Genet Cytogenet. 2003 Feb;141(1):14-9 PubMed

Leukemia. 2007 Nov;21(11):2332-43 PubMed

Cancer Genet Cytogenet. 1998 Jun;103(2):140-3 PubMed

Blood. 2001 Aug 15;98(4):945-51 PubMed